Cargando…
Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis
Vision impairment due to optic neuritis (ON) is one of the major clinical presentations in Multiple Sclerosis (MS) and is characterized by inflammation and degeneration of the optic nerve and retina. Currently available treatments are only partially effective and have a limited impact on the neuroin...
Autores principales: | Candadai, Amritha A., Liu, Fang, Fouda, Abdelrahman Y., Alfarhan, Moaddey, Palani, Chithra D., Xu, Zhimin, Caldwell, Ruth B., Narayanan, S. Priya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971528/ https://www.ncbi.nlm.nih.gov/pubmed/33735314 http://dx.doi.org/10.1371/journal.pone.0247901 |
Ejemplares similares
-
Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis
por: Candadai, Amritha A., et al.
Publicado: (2021) -
Retinal Neuroprotection From Optic Nerve Trauma by Deletion of Arginase 2
por: Xu, Zhimin, et al.
Publicado: (2018) -
Calbindin 2-specific deletion of arginase 2 preserves visual function after optic nerve crush
por: Zaidi, Syed A. H., et al.
Publicado: (2023) -
Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?
por: Shosha, Esraa, et al.
Publicado: (2020) -
Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
por: Fouda, Abdelrahman Y., et al.
Publicado: (2020)